Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

With the rapid increase in provision of deep brain stimulation for Parkinson's disease, the efficacy of pallidotomy in symptom alleviation appears to be increasingly ignored. We demonstrate that lesional surgery is effective with benefit over a significant period of time with very significant societal cost savings. Such studies are essential for future planning of services so that maximum numbers of patients can benefit from surgery, both lesional and neuromodulation, as deemed appropriate.

Original publication

DOI

10.1016/j.jocn.2004.03.007

Type

Journal article

Journal

J Clin Neurosci

Publication Date

11/2004

Volume

11

Pages

829 - 834

Keywords

Adult, Aged, Aged, 80 and over, Antiparkinson Agents, Cohort Studies, Costs and Cost Analysis, Female, Humans, Male, Middle Aged, Neurologic Examination, Pallidotomy, Parkinson Disease, Severity of Illness Index, Treatment Outcome